Clinical Trial Update: Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GSK1278863 for anemia in Japanese patients on hemodialysis; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 2 | Status: COMPLETED | Results posted: 2018-02-12